Page 13 Acute Pain Management
P. 13




5.3

 Adjuvant
Drugs ........................................................................................................ 131

5.3.1

 Alpha‐2
agonists................................................................................................131

5.3.2
 Adrenaline.........................................................................................................132

5.3.3

 Ketamine ...........................................................................................................133

5.3.4

 Midazolam.........................................................................................................134

5.3.5

 Neostigmine ......................................................................................................134

5.3.6

 Magnesium........................................................................................................135

5.3.7

 Botulinum
toxin
A..............................................................................................135

5.4

 Anti‐inflammatory
drugs.......................................................................................... 136
 CONTENTS

5.4.1

 Corticosteroids ..................................................................................................136

5.4.2

 Non‐steroidal
anti‐inflammatory
drugs.............................................................137

References ....................................................................................................................... 138

6.
 ADMINISTRATION
OF
SYSTEMIC
ANALGESIC
DRUGS................................................. 150

6.1
 Oral
route ................................................................................................................ 150

6.1.1
 Opioids
and
tramadol........................................................................................153

6.1.2
 Non‐selective
non‐steroidal
anti‐inflammatory
drugs
and
coxibs ....................154

6.1.3
 Paracetamol ......................................................................................................155

6.2
 Intravenous
route .................................................................................................... 155

6.2.1
 Opioids
and
tramadol........................................................................................155

6.2.2
 Non‐selective
non‐steroidal
anti‐inflammatory
drugs
and
coxibs ....................156

6.2.3
 Paracetamol ......................................................................................................156

6.3
 Intramuscular
and
subcutaneous
routes................................................................... 157

6.3.1
 Opioids
and
tramadol........................................................................................157

6.3.2
 Non‐selective
non‐steroidal
anti‐inflammatory
drugs
and
coxibs ....................158

6.4
 Rectal
route ............................................................................................................. 158

6.4.1
 Opioids ..............................................................................................................158

6.4.2
 Non‐selective
non‐steroidal
anti‐inflammatory
drugs ......................................158

6.4.3
 Paracetamol ......................................................................................................159

6.5
 Transdermal
route ................................................................................................... 159

6.5.1
 Opioids ..............................................................................................................159

6.5.2
 Other
drugs .......................................................................................................160

6.6
 Transmucosal
routes ................................................................................................ 160

6.6.1
 Intranasal
route.................................................................................................160

6.6.2
 Sublingual
and
buccal
routes.............................................................................162

6.6.3
 Inhaled...............................................................................................................163

References ....................................................................................................................... 164














 Acute
pain
management:
scientific
evidence
 xiii

   8   9   10   11   12   13   14   15   16   17   18